Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

11619488

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides materials and methods for screening for and treating hereditary lymphedema in human subjects.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LUDWIG INSTITUTE FOR CANCER RESEARCHNEW YORK NEW YORK 10105

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alitalo, Kari Helsinki, FI 130 1966
Ferrell, Robert E Pittsburgh, PA 12 43
Finegold, David N Pittsburgh, PA 8 24
Karkkainen, Marika Espoo, FI 14 182

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation